Sutro Biopharma Inc

NASDAQ:STRO  
18.57
-0.24 (-1.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)845.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$12.99 Million
Adjusted EPS-$0.40
See more estimates
10-Day MA$18.62
50-Day MA$19.74
200-Day MA$18.83
See more pivots

Sutro Biopharma Inc Stock, NASDAQ:STRO

310 Utah Avenue, Suite 150, South San Francisco, California 94080
Phone: +1.650.392.8412
Number of Employees: 191

Description

Sutro Biopharma Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.